Korn Ferry (KFY)
NYSE: KFY
· Real-Time Price · USD
68.11
2.06 (3.12%)
At close: May 12, 2025, 3:25 PM
Korn Ferry Revenue Breakdown
| Period Ending | Apr 30, 2024 | Apr 30, 2023 | Apr 30, 2022 | Apr 30, 2021 | Apr 30, 2020 | Apr 30, 2019 |
|---|---|---|---|---|---|---|
| Consumer Goods Revenue | 382.18M | 386.41M | 372.72M | 239.46M | 285.93M | 297.68M |
| Consumer Goods Revenue Growth | -1.10% | +3.67% | +55.65% | -16.25% | -3.95% | n/a |
| Education Non Profit And General Revenue | 184.93M | 143.3M | 131.81M | 116.57M | 126.67M | 349.97M |
| Education Non Profit And General Revenue Growth | +29.05% | +8.72% | +13.07% | -7.97% | -63.81% | n/a |
| Financial Service Revenue | 491.76M | 494.3M | 475.33M | 331.98M | 334.43M | 561.03M |
| Financial Service Revenue Growth | -0.51% | +3.99% | +43.18% | -0.73% | -40.39% | n/a |
| Industrial Revenue | 813.92M | 805.24M | 688.9M | 490.86M | 556.19M | 323.09M |
| Industrial Revenue Growth | +1.08% | +16.89% | +40.35% | -11.75% | +72.15% | n/a |
| Life Sciences And Healthcare Revenue | 485.32M | 522.37M | 501.46M | 355.67M | 343.95M | 260.92M |
| Life Sciences And Healthcare Revenue Growth | -7.09% | +4.17% | +40.99% | +3.41% | +31.82% | n/a |
| Service Revenue | 2.76B | 2.84B | 456.5M | 275.51M | 285.56M | n/a |
| Service Revenue Growth | -2.57% | +521.12% | +65.69% | -3.52% | n/a | n/a |
| Technology Service Revenue | 404.57M | 483.79M | n/a | n/a | n/a | n/a |
| Technology Service Revenue Growth | -16.37% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 | Jul 31, 2019 | Apr 30, 2019 | Jan 31, 2019 | Oct 31, 2018 | Jul 31, 2018 | Apr 30, 2018 | Jan 31, 2018 | Oct 31, 2017 | Jul 31, 2017 | Apr 30, 2017 | Jan 31, 2017 | Oct 31, 2016 | Jul 31, 2016 | Apr 30, 2016 | Jan 31, 2016 | Oct 31, 2015 | Jul 31, 2015 | Apr 30, 2015 | Jan 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 65.33M | 64.54M | 60M | 60.31M | 60.46M | 519.6M | 545.8M | 557.56M | 552.17M | 529.85M | 530.08M | 529.84M | 506.68M | 495.7M | 446.5M | 431.29M | 373.6M | 353.66M | 331.1M | 343.31M | 419.95M | 399.39M | 394.3M | 396.01M | 383.01M | 393.57M | 490.63M | 379.88M | 369.27M | 359.65M | 332.21M | 335.43M | 319.26M | 324.74M | 318.31M | 360.42M | 299.82M | 233.17M | 216.95M | 224.52M | 201.57M |
| Selling, General, and Administrative Revenue Growth | +1.21% | +7.57% | -0.52% | -0.24% | -88.36% | -4.80% | -2.11% | +0.98% | +4.21% | -0.04% | +0.05% | +4.57% | +2.21% | +11.02% | +3.53% | +15.44% | +5.64% | +6.81% | -3.55% | -18.25% | +5.15% | +1.29% | -0.43% | +3.39% | -2.68% | -19.78% | +29.15% | +2.87% | +2.68% | +8.26% | -0.96% | +5.07% | -1.69% | +2.02% | -11.68% | +20.21% | +28.59% | +7.48% | -3.37% | +11.39% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |